bis(N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide);N-[6-methoxy-2-(4-oxocyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide

C65H65F9N12O9 — CID 164969176

IUPACbis(N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide);N-[6-methoxy-2-(4-oxocyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
SMILESCOc1cc2nn(C3CCC(=O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(C)(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(C)(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1
InChIInChI=1S/2C22H23F3N4O3.C21H19F3N4O3/c2*1-21(31)8-6-14(7-9-21)29-12-13-10-17(18(32-2)11-16(13)28-29)27-20(30)15-4-3-5-19(26-15)22(23,24)25;1-31-18-10-16-12(11-28(27-16)13-5-7-14(29)8-6-13)9-17(18)26-20(30)15-3-2-4-19(25-15)21(22,23)24/h2*3-5,10-12,14,31H,6-9H2,1-2H3,(H,27,30);2-4,9-11,13H,5-8H2,1H3,(H,26,30)
InChIKeyCWSWJIJMBPDHCK-UHFFFAOYSA-N
MW1329.29 g/mol
LogP13.55
Rot. Bonds12

About bis(N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide);N-[6-methoxy-2-(4-oxocyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide

bis(N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide);N-[6-methoxy-2-(4-oxocyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide (PubChem CID 164969176) has the molecular formula C65H65F9N12O9 and a molecular weight of 1329.29 g/mol. Its IUPAC name is bis(N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide);N-[6-methoxy-2-(4-oxocyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide.

Molecular Properties

Compound Namebis(N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide);N-[6-methoxy-2-(4-oxocyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
PubChem CID164969176
Molecular FormulaC65H65F9N12O9
Molecular Weight1329.29 g/mol
Exact Mass1328.49
IUPAC Namebis(N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide);N-[6-methoxy-2-(4-oxocyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
SMILESCOc1cc2nn(C3CCC(=O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(C)(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(C)(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1
InChIInChI=1S/2C22H23F3N4O3.C21H19F3N4O3/c2*1-21(31)8-6-14(7-9-21)29-12-13-10-17(18(32-2)11-16(13)28-29)27-20(30)15-4-3-5-19(26-15)22(23,24)25;1-31-18-10-16-12(11-28(27-16)13-5-7-14(29)8-6-13)9-17(18)26-20(30)15-3-2-4-19(25-15)21(22,23)24/h2*3-5,10-12,14,31H,6-9H2,1-2H3,(H,27,30);2-4,9-11,13H,5-8H2,1H3,(H,26,30)
InChIKeyCWSWJIJMBPDHCK-UHFFFAOYSA-N
XLogP13.55
TPSA264.65 Ų
H-Bond Donors5
H-Bond Acceptors18
Rotatable Bonds12
Heavy Atoms95
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001329.29
LogP ≤ 513.55
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1018

Analyze bis(N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide);N-[6-methoxy-2-(4-oxocyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of bis(N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide);N-[6-methoxy-2-(4-oxocyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The IUPAC name of bis(N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide);N-[6-methoxy-2-(4-oxocyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide (CID 164969176) is bis(N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide);N-[6-methoxy-2-(4-oxocyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide.
What is the SMILES notation for bis(N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide);N-[6-methoxy-2-(4-oxocyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The canonical SMILES for bis(N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide);N-[6-methoxy-2-(4-oxocyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide is COc1cc2nn(C3CCC(=O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(C)(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CCC(C)(O)CC3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.
What is the InChIKey of bis(N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide);N-[6-methoxy-2-(4-oxocyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
The InChIKey is CWSWJIJMBPDHCK-UHFFFAOYSA-N. The full InChI is InChI=1S/2C22H23F3N4O3.C21H19F3N4O3/c2*1-21(31)8-6-14(7-9-21)29-12-13-10-17(18(32-2)11-16(13)28-29)27-20(30)15-4-3-5-19(26-15)22(23,24)25;1-31-18-10-16-12(11-28(27-16)13-5-7-14(29)8-6-13)9-17(18)26-20(30)15-3-2-4-19(25-15)21(22,23)24/h2*3-5,10-12,14,31H,6-9H2,1-2H3,(H,27,30);2-4,9-11,13H,5-8H2,1H3,(H,26,30).
What are the key properties of bis(N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide);N-[6-methoxy-2-(4-oxocyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide?
bis(N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide);N-[6-methoxy-2-(4-oxocyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide has a molecular weight of 1329.29 g/mol, XLogP of 13.55, 12 rotatable bonds, 5 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for bis(N-[2-(4-hydroxy-4-methylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide);N-[6-methoxy-2-(4-oxocyclohexyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide is sourced from PubChem (CID 164969176), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).